Results 211 to 220 of about 61,152 (267)

Gips

, 2004
openaire   +1 more source

Comparison of oral versus intravenous glucose exposure on plasma growth hormone levels: a crossover study in healthy volunteers. [PDF]

Pituitary
Vinten AK, Jørgensen NT, Budtz-Jørgensen E, Klose M, Andreassen M.   +4 more
europepmc   +1 more source

Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review. [PDF]

Curr Obes Rep
Tzeravini E, Simati S, Anastasiou IA, Dalamaga M, Kokkinos A.   +4 more
europepmc   +1 more source

First Evaluation of Roux-en-Y Gastric Bypass as a Novel Surgical Treatment for Diabetes and Glucose Metabolism Regulation in Cats. [PDF]

Vet Sci
Li L, Yuan G, Xiong Q, Hao W, Yang L.
europepmc   +1 more source

National Utilization and Expenditure Trends of GLP-1 Receptor Agonists and Dual GLP-1/GIP Agonist in Croatia, 2017-2024. [PDF]

Medicina (Kaunas)
Car M, Erceg D, Udovičić M, Bokun T, Rahelić D.   +4 more
europepmc   +1 more source

RFX6 maturity-onset diabetes of the young: clinical considerations and novel use of tirzepatide. [PDF]

Endocrinol Diabetes Metab Case Rep
Gopalakrishnan PP, Banerjee A, Milne R, Smith R, McNulty SJ, Bujawansa S, Narayanan RP.   +6 more
europepmc   +1 more source

Topical Volumizing Cream Improves Facial Volume and Skin Health in Adults With Rapid Weight Loss From Pharmacologic (GLP-1/GIP Agonists), Surgical, or Behavioral Interventions. [PDF]

J Cosmet Dermatol
Nguyen N, Aguilar A, Afzal N, Lee A, Akram W, Duong MN, Sivamani RK.   +6 more
europepmc   +1 more source

A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Efficacy and Adverse Events. [PDF]

Arch Clin Med Case Rep
Radparvar I, Agrawal DK.
europepmc   +1 more source

GLP-1 agonist-associated presentations to unscheduled care: An opportunistic pilot study. [PDF]

Br J Clin Pharmacol
Thomas O, Coulson JM.
europepmc   +1 more source